Dr. Gordon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10000 W Bluemound Rd
Wauwatosa, WI 53226Phone+1 414-454-8000Fax+1 414-805-3888
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Dermatology, 1993 - 1996
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1990 - 1993
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1990
Certifications & Licensure
- IL State Medical License 1993 - 2026
- WI State Medical License 2016 - 2025
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Effect of spesolimab on sustained disease control in patients with generalized pustular psoriasis: Post hoc analysis of the EFFISAYIL 2 study.Kenneth B Gordon, Matthias Augustin, Jonathan Barker, Yayoi Tada, Mark G Lebwohl
Journal of the American Academy of Dermatology. 2025-03-07 - Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and P...April W Armstrong, Matthias Augustin, Jennifer L Beaumont, Tan P Pham, Stacie Hudgens
Dermatology and Therapy. 2025-03-06 - Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions.Kenneth B Gordon, Yayoi Tada, Milan J Anadkat, Siew Eng Choon, Boni Elewski
Dermatology and Therapy. 2025-02-01
Press Mentions
- Bimzelx Shows Consistent Safety Profile Compared with Similar Psoriasis TreatmentsJune 14th, 2022
- Risankizumab Shown to Be Safe over the Long TermMarch 18th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: